Results 71 to 80 of about 756 (179)

Guideline for gynecological practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2023 edition

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 50, Issue 7, Page 1073-1094, July 2024.
Abstract Twelve years after the first edition of The Guideline for Gynecological Practice, which was jointly edited by The Japan Society of Obstetrics and Gynecology and The Japan Association of Obstetricians and Gynecologists, the 5th Revised Edition was published in 2023.
Eiji Nishio   +35 more
wiley   +1 more source

Eldecalcitol, in Combination with Bisphosphonate, Is Effective for Treatment of Japanese Osteoporotic Patients

open access: yesThe Tohoku Journal of Experimental Medicine, 2015
Alfacalcidol (ALF) and eldecalcitol (ELD) are vitamin D analogues that can be combined with anti-resorption drugs, such as bisphosphonate (BP) for the treatment of osteoporosis (OP). There has been no report comparing the effects of those vitamin D analogs in combination with BPs.
Mukaiyama, Keijiro   +6 more
openaire   +3 more sources

Pyoderma gangrenosum‐like lesions in the setting of IgA cutaneous vasculitis: Favourable response to adalimumab

open access: yesSkin Health and Disease, Volume 4, Issue 2, April 2024.
Pyoderma gangrenosum is a rare inflammatory skin disease classified within the group of neutrophilic dermatoses, and clinically characterised by painful, rapidly evolving cutaneous ulcers with undermined, irregular, erythematous‐violaceous edges. Underlying diseases include rheumatoid arthritis, inflammatory bowel disease, haematopoietic malignancy ...
Hitomi Sugino   +4 more
wiley   +1 more source

Serious: Non-serious ratios over time.

open access: yes, 2015
(A) capecitabine, (B) eldecalcitol, (C) epoetin beta pegol, (D) peginterferon alfa-2a, and (E) sevelamer hydrochloride.
Seigo Okugawa (733308)   +10 more
core   +1 more source

Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys [PDF]

open access: yes, 2013
Vitamin D insufficiency is common in elderly people worldwide, and intake of supplementary calcium and vitamin D is recommended to those with a high risk of fracture.
Chouinard, Luc   +4 more
core   +1 more source

Relationship between Hypercalcemia and Renal Function with Eldecalcitol

open access: yesYAKUGAKU ZASSHI
Eldecalcitol (ELD), an active vitamin D3 analog, is extensively prescribed in Japan for the treatment of osteoporosis. However, hypercalcemia remains a significant concern, particularly in patients with impaired renal function. Data on the extent to which renal dysfunction increases the risk of hypercalcemia are limited.
Shinji, Oda   +4 more
openaire   +2 more sources

Pd(0)‐Catalyzed‐Mediated Synthesis of Vitamin D Compounds

open access: yesAdvanced Synthesis &Catalysis, Volume 366, Issue 4, Page 603-616, February 20, 2024.
Abstract 1α,25‐Dihydroxyvitamin D3 (1,25D3), the hormonally active form of vitamin D3, regulates mineral homeostasis, cell growth, cell differentiation‐proliferation, apoptosis, and immune responses. 1,25D3 activates more than 229 genes associated with several diseases, including arthritis, diabetes and cancer, suggesting its implications in a broader ...
Antonio Mouriño
wiley   +1 more source

case report form.xlsx

open access: yes, 2022
The data includes the sample of case report in the protocol article: a randomized study of the efficacy of ibandronic acid plus eldecalcitol in patients with gastric cancer after gastrectomy: A comparative study of different routes of administration of ...
Hisaki Aiba (12989435)
core   +1 more source

Liver stiffness as a cornerstone in heart disease risk assessment

open access: yesLiver International, Volume 44, Issue 2, Page 344-356, February 2024.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) typically presents with hepatic fibrosis in advanced disease, resulting in increased liver stiffness. A subset of patients further develops liver cirrhosis and hepatocellular carcinoma.
Joost Boeckmans   +3 more
wiley   +1 more source

High prominence:Low prominence ratios over time.

open access: yes, 2015
(A) capecitabine, (B) eldecalcitol, (C) epoetin beta pegol, (D) peginterferon alfa-2a, and (E) sevelamer hydrochloride.
Seigo Okugawa (733308)   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy